Our recent work indicates that the PKCα-KR-CLL model exhibits key characteristics of poor prognostic CLL, with cells expressing ZAP-70 and possessing enhanced proliferative capacity both in vivo and in vitro. The gene discussed is PRKCA; the disease is B-cell chronic lymphocytic leukemia.